What companies does Rosecliff Venture Partners invest in?

Rosecliff Venture Partners has 36 recorded portfolio companies, including SpaceX, OpenAI, Scale AI.

What is Rosecliff Venture Partners's AUM?

Rosecliff Venture Partners manages approximately $1.0B in assets.

Is Rosecliff Venture Partners actively investing?

Rosecliff Venture Partners's most recent recorded investment was in Sep 2025, with 1 investments in the last 12 months.

PrivateMarketView

Rosecliff Venture Partners key facts

Rosecliff Venture Partners is an investor based in New York, New York with 36 tracked portfolio companies.
Notable positions include SpaceX, OpenAI, Scale AI.
PrivateMarketView records 4 deal participations by Rosecliff Venture Partners.
Rosecliff Venture Partners’s most recent recorded investment was in Sep 2025, one of 1 in the last 12 months.

About Rosecliff Venture Partners

Rosecliff Venture Partners is a venture capital firm based in New York. Founded in 2016, the firm invests in companies operating in the technology, financial, consumer, healthcare, and software industries. This firm is a Registered Investment Adviser (RIA).

Stages

Debt - GeneralDebt RefinancingEarly Stage VCLater Stage VCPE Growth/ExpansionPIPESecondary Transaction - PrivateSeed Round

Sectors

AirApplication SoftwareBeveragesCapital Markets/InstitutionsFood ProductsHealthcare Devices and SuppliesMediaOther Consumer Products and ServicesOther Financial ServicesSocial/Platform SoftwareTelecommunications Service ProvidersPreferred Deal TypesDebt - GeneralDebt Refinancing

Investment focus

Rosecliff Venture Partners invests at the debt - general, debt refinancing, early stage vc, later stage vc, pe growth/expansion, pipe, secondary transaction - private and seed round stages, with a focus on Air, Application Software, Beverages, Capital Markets/Institutions, Food Products and Healthcare Devices and Supplies.

Investment activity

Rosecliff Venture Partners joined 2 recorded rounds in the last two years, in line with the 2 in the two years before. By year: 2 in 2025 and 2 in 2024. Most recently: Perplexity AI (Series E, Sep 2025) and OpenAI (Series F, Mar 2025).

Rosecliff Venture Partners portfolio at a glance

36 portfolio companies are on record for Rosecliff Venture Partners, including SpaceX, OpenAI and Scale AI.

32 of the 36 carry a recorded valuation and 6 have recorded secondary-market trades, the names a secondary buyer or seller can price.

Free account

See more of the book

·The top 10 names in the book — of 36 recorded positions
·The 10 latest deals — of 4 rounds
·Watchlist + alerts for Rosecliff Venture Partners's activity

Create free account

Membership and data by Private Market View

No card required

Portfolio

36 companies · priced for members

Company	Industry	Valuation	First invested	Role
SpaceX	Aerospace and Defense	▮	▮	▮
OpenAI	Software Development Applications	▮	▮	▮
Scale AI	Business/Productivity Software	▮	▮	▮
+ 33 more companies · all 36, priced and dated or a free account shows the top 10 names — no card The whole book · Pro $99 a month Membership and data by Private Market View

Rosecliff Venture Partners recent deals

4 recorded

Sep 2025Perplexity AISeries E▮

Mar 2025OpenAISeries F▮

Aug 2024InterluneSeed Round▮

+ 1 more deals · amounts and lead flags are a member featureUnlock all 4 deals

Membership and data by Private Market View

Rosecliff Venture Partners working numbers

the prospecting layer

Typical check

▮

Check sizes, follow-on behavior, holding periods — what a pitch needs. Pro.Unlock working numbers

Membership and data by Private Market View

Frequently asked about Rosecliff Venture Partners

What companies does Rosecliff Venture Partners invest in?: Rosecliff Venture Partners has 36 recorded portfolio companies, including SpaceX, OpenAI, Scale AI.
What is Rosecliff Venture Partners's AUM?: Rosecliff Venture Partners manages approximately $1.0B in assets.
Is Rosecliff Venture Partners actively investing?: Rosecliff Venture Partners's most recent recorded investment was in Sep 2025, with 1 investments in the last 12 months.